| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Study of the in vitro antagonistic activity of various single-strain and multi-strain probiotics against Escherichia coli
Authors:ID Fijan, Sabina (Author)
ID Šulc, Dunja (Author)
ID Steyer, Andrej (Author)
Files:.pdf 2018-Fijan_et_al-ijerph-E_coli.pdf (413,59 KB)
MD5: 6BA894B17E775C5191776972FD0BD1DB
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:FZV - Faculty of Health Sciences
Abstract:Escherichia coli is an important commensal of our gut, however, many pathogenic strains exist, causing various severe infections in the gut or beyond. Due to several antibiotic resistance patterns of E. coli, research of alternative treatments or adjuvant therapy is important. One of these is the use of probiotics as antagonistic agents against E. coli. Most published studies investigate only one strain of E. coli and single-strain probiotics. The objectives of this study were to evaluate the antagonistic activity of selected single-strain and multi-strain probiotic supplements against selected clinical E. coli pathotypes using the in vitro agar spot test and the co-culturing method. Molecular methods were used to determine the presence of the genus lactobacilli and bifidobacteria as well as certain selected strains in the probiotic supplements. The agar-spot test showed that the multi-strain probiotics were more effective than the single-strain probiotics. On the other hand, the co-culturing method showed the opposite result, indicating that results are importantly influenced by the chosen method. The most effective single-strain probiotics against E. coli strains were Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus reuteri DSM 17938. The most effective multi-strain probiotics contained lactobacilli, bifidobacteria and enterococci strains, thus proving that most effective probiotics against E. coli strains are the lactic acid bacteria and bifidobacteria. The overall results from both in vitro tests reveal that all selected probiotics exhibited an antagonistic activity against all E. coli strains. From a public health perspective probiotics have thus proved to be successful in inhibiting the growth of E. coli and could therefore be used as adjuvant therapy or alternative therapy in E. coli infections.
Keywords:probiotic, Escherichia coli, antagonistic effect
Publication status:Published
Publication version:Version of Record
Submitted for review:06.06.2018
Article acceptance date:13.07.2018
Publication date:20.07.2018
Publisher:MDPI
Year of publishing:2018
Number of pages:str. 1-15
Numbering:Letn. 15, št. 7
PID:20.500.12556/DKUM-95798 New window
UDC:579
ISSN on article:1660-4601
COBISS.SI-ID:33872089 New window
DOI:10.3390/ijerph15071539 New window
Publication date in DKUM:23.10.2025
Views:118
Downloads:9
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:20.07.2018

Secondary language

Language:Slovenian
Keywords:probiotik, Escherichia coli, antagonističen učinek


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica